Abstract
Although apolipoproteins (apo) were initially acknowledged as major determinants in lipoprotein metabolism and cardiovascular disease, the findings of recent studies have revealed the significance of multiple apolipoprotein classes and subclasses in various biological processes and pathophysiological pathways [...].
Publication types
-
Editorial
-
Introductory Journal Article
MeSH terms
-
Animals
-
Apolipoproteins* / metabolism
-
Cardiovascular Diseases* / metabolism
-
Humans
Grants and funding
This work was partly funded by Instituto de Salud Carlos III and FEDER “Una manera de hacer Europa” grant PI23/00232 (to J.C.E.-G). CIBERDEM is an Instituto de Salud Carlos III project.